More importantly, our univariate and multivariate Cox regression assays both revealed that status of ZEB2‐AS1 expression was an independent prognostic factor for HNSCC survival (Table S2), strongly suggesting its potential as a novel prognostic biomarker. This evidence concerns the gene ZEB2 and head and neck squamous cell carcinoma.